Annual CAPEX
$871.40 K
+$626.80 K+256.26%
December 31, 2023
Summary
- As of February 24, 2025, OPRX annual capital expenditures is $871.40 thousand, with the most recent change of +$626.80 thousand (+256.26%) on December 31, 2023.
- During the last 3 years, OPRX annual CAPEX has risen by +$746.70 thousand (+598.80%).
- OPRX annual CAPEX is now -45.12% below its all-time high of $1.59 million, reached on December 31, 2019.
Performance
OPRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$92.00 K
+$7000.00+8.24%
September 30, 2024
Summary
- As of February 24, 2025, OPRX quarterly capital expenditures is $92.00 thousand, with the most recent change of +$7000.00 (+8.24%) on September 30, 2024.
- Over the past year, OPRX quarterly CAPEX has stayed the same.
- OPRX quarterly CAPEX is now -91.66% below its all-time high of $1.10 million, reached on June 30, 2023.
Performance
OPRX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
-$445.60 K
-$229.00 K-105.72%
September 30, 2024
Summary
- As of February 24, 2025, OPRX TTM capital expenditures is -$445.60 thousand, with the most recent change of -$229.00 thousand (-105.72%) on September 30, 2024.
- Over the past year, OPRX TTM CAPEX has stayed the same.
- OPRX TTM CAPEX is now -126.71% below its all-time high of $1.67 million, reached on September 30, 2023.
Performance
OPRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
OPRX CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +256.3% | 0.0% | 0.0% |
3 y3 years | +598.8% | -7.1% | -191.7% |
5 y5 years | +857.6% | -82.5% | -128.1% |
OPRX CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +256.3% | -91.7% | +111.9% | -126.7% | at low |
5 y | 5-year | -45.1% | +598.8% | -91.7% | +111.9% | -126.7% | at low |
alltime | all time | -45.1% | +8120.8% | -91.7% | +111.9% | -126.7% | at low |
OptimizeRx CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $92.00 K(+8.2%) | -$445.60 K(+105.7%) |
Jun 2024 | - | $85.00 K(-44.4%) | -$216.60 K(-127.0%) |
Mar 2024 | - | $153.00 K(-119.7%) | $801.40 K(-8.0%) |
Dec 2023 | $871.40 K(+256.3%) | -$775.60 K(-341.6%) | $871.40 K(-47.8%) |
Sep 2023 | - | $321.00 K(-70.9%) | $1.67 M(+20.6%) |
Jun 2023 | - | $1.10 M(+394.6%) | $1.38 M(+244.4%) |
Mar 2023 | - | $223.00 K(+932.4%) | $401.80 K(+64.3%) |
Dec 2022 | $244.60 K(-49.7%) | $21.60 K(-40.7%) | $244.60 K(-24.0%) |
Sep 2022 | - | $36.40 K(-69.9%) | $322.00 K(-28.8%) |
Jun 2022 | - | $120.80 K(+83.6%) | $452.10 K(-3.2%) |
Mar 2022 | - | $65.80 K(-33.5%) | $467.20 K(-3.9%) |
Dec 2021 | $486.00 K(+289.7%) | $99.00 K(-40.5%) | $486.00 K(+4.2%) |
Sep 2021 | - | $166.50 K(+22.5%) | $466.50 K(+45.6%) |
Jun 2021 | - | $135.90 K(+60.6%) | $320.30 K(+65.5%) |
Mar 2021 | - | $84.60 K(+6.4%) | $193.50 K(+55.0%) |
Dec 2020 | $124.70 K(-92.1%) | $79.50 K(+291.6%) | $124.80 K(-78.2%) |
Sep 2020 | - | $20.30 K(+123.1%) | $571.60 K(+1.2%) |
Jun 2020 | - | $9100.00(-42.8%) | $565.00 K(-64.5%) |
Mar 2020 | - | $15.90 K(-97.0%) | $1.59 M(+0.1%) |
Dec 2019 | $1.59 M(+1644.7%) | $526.30 K(+3741.6%) | $1.59 M(+48.0%) |
Sep 2019 | - | $13.70 K(-98.7%) | $1.07 M(+0.3%) |
Jun 2019 | - | $1.03 M(+7392.0%) | $1.07 M(+1468.0%) |
Mar 2019 | - | $13.80 K(+23.2%) | $68.20 K(-25.1%) |
Dec 2018 | $91.00 K(+115.6%) | $11.20 K(+6.7%) | $91.00 K(-473.0%) |
Sep 2018 | - | $10.50 K(-67.9%) | -$24.40 K(-535.7%) |
Jun 2018 | - | $32.70 K(-10.7%) | $5600.00(-91.1%) |
Mar 2018 | - | $36.60 K(-135.1%) | $62.70 K(+48.6%) |
Dec 2017 | $42.20 K(-87.9%) | -$104.20 K(-357.3%) | $42.20 K(-84.4%) |
Sep 2017 | - | $40.50 K(-54.9%) | $270.90 K(-22.5%) |
Jun 2017 | - | $89.80 K(+457.8%) | $349.40 K(-0.1%) |
Mar 2017 | - | $16.10 K(-87.1%) | $349.80 K(+0.1%) |
Dec 2016 | $349.50 K | $124.50 K(+4.6%) | $349.50 K(+59.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2016 | - | $119.00 K(+31.9%) | $218.90 K(+37.1%) |
Jun 2016 | - | $90.20 K(+470.9%) | $159.70 K(+70.1%) |
Mar 2016 | - | $15.80 K(-359.0%) | $93.90 K(-6.9%) |
Dec 2015 | $101.00 K(-75.4%) | -$6100.00(-110.2%) | $100.90 K(-47.7%) |
Sep 2015 | - | $59.80 K(+145.1%) | $192.90 K(-20.7%) |
Jun 2015 | - | $24.40 K(+7.0%) | $243.30 K(-24.8%) |
Mar 2015 | - | $22.80 K(-73.5%) | $323.50 K(-21.1%) |
Dec 2014 | $410.00 K(+37.3%) | $85.90 K(-22.1%) | $410.00 K(-21.5%) |
Sep 2014 | - | $110.20 K(+5.4%) | $522.20 K(+10.1%) |
Jun 2014 | - | $104.60 K(-4.3%) | $474.30 K(+25.6%) |
Mar 2014 | - | $109.30 K(-44.8%) | $377.60 K(+26.4%) |
Dec 2013 | $298.60 K(+486.6%) | $198.10 K(+218.0%) | $298.70 K(+196.9%) |
Sep 2013 | - | $62.30 K(+688.6%) | $100.60 K(+203.0%) |
Jun 2013 | - | $7900.00(-74.0%) | $33.20 K(-30.3%) |
Mar 2013 | - | $30.40 K(>+9900.0%) | $47.60 K(-6.5%) |
Dec 2012 | $50.90 K(-78.3%) | $0.00(-100.0%) | $50.90 K(-61.3%) |
Sep 2012 | - | -$5100.00(-122.9%) | $131.40 K(-36.9%) |
Jun 2012 | - | $22.30 K(-33.8%) | $208.10 K(-9.9%) |
Mar 2012 | - | $33.70 K(-58.1%) | $231.00 K(-1.7%) |
Dec 2011 | $234.90 K(+4.1%) | $80.50 K(+12.4%) | $234.90 K(+12.2%) |
Sep 2011 | - | $71.60 K(+58.4%) | $209.30 K(-4.3%) |
Jun 2011 | - | $45.20 K(+20.2%) | $218.70 K(+0.1%) |
Mar 2011 | - | $37.60 K(-31.5%) | $218.50 K(-3.1%) |
Dec 2010 | $225.60 K(+109.5%) | $54.90 K(-32.2%) | $225.60 K(+32.2%) |
Sep 2010 | - | $81.00 K(+80.0%) | $170.70 K(+90.3%) |
Jun 2010 | - | $45.00 K(+0.7%) | $89.70 K(+100.7%) |
Mar 2010 | - | $44.70 K(-341.6%) | $44.70 K(+317.8%) |
Dec 2009 | $107.70 K(+916.0%) | - | - |
Dec 2008 | $10.60 K(-91.6%) | -$18.50 K(<-9900.0%) | $10.70 K(-63.4%) |
Sep 2008 | - | $0.00(-100.0%) | $29.20 K(0.0%) |
Jun 2008 | - | $21.80 K(+194.6%) | $29.20 K(+294.6%) |
Mar 2008 | - | $7400.00 | $7400.00 |
Dec 2007 | $125.60 K | - | - |
FAQ
- What is OptimizeRx annual capital expenditures?
- What is the all time high annual CAPEX for OptimizeRx?
- What is OptimizeRx annual CAPEX year-on-year change?
- What is OptimizeRx quarterly capital expenditures?
- What is the all time high quarterly CAPEX for OptimizeRx?
- What is OptimizeRx quarterly CAPEX year-on-year change?
- What is OptimizeRx TTM capital expenditures?
- What is the all time high TTM CAPEX for OptimizeRx?
- What is OptimizeRx TTM CAPEX year-on-year change?
What is OptimizeRx annual capital expenditures?
The current annual CAPEX of OPRX is $871.40 K
What is the all time high annual CAPEX for OptimizeRx?
OptimizeRx all-time high annual capital expenditures is $1.59 M
What is OptimizeRx annual CAPEX year-on-year change?
Over the past year, OPRX annual capital expenditures has changed by +$626.80 K (+256.26%)
What is OptimizeRx quarterly capital expenditures?
The current quarterly CAPEX of OPRX is $92.00 K
What is the all time high quarterly CAPEX for OptimizeRx?
OptimizeRx all-time high quarterly capital expenditures is $1.10 M
What is OptimizeRx quarterly CAPEX year-on-year change?
Over the past year, OPRX quarterly capital expenditures has changed by $0.00 (0.00%)
What is OptimizeRx TTM capital expenditures?
The current TTM CAPEX of OPRX is -$445.60 K
What is the all time high TTM CAPEX for OptimizeRx?
OptimizeRx all-time high TTM capital expenditures is $1.67 M
What is OptimizeRx TTM CAPEX year-on-year change?
Over the past year, OPRX TTM capital expenditures has changed by $0.00 (0.00%)